Ashley M. Keating - 17 May 2024 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 May 2024, 16:47:07 UTC
Prior SEC filing
18 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Ashley M. Keating

Key filing fact

Ashley M. Keating filed Form 4 for Medpace Holdings, Inc. (MEDP) on 21 May 2024.

Key facts

  • This page summarizes Ashley M. Keating's Form 4 filing for Medpace Holdings, Inc. (MEDP).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 21 May 2024, 16:47.

Change

  • Previous filing in this sequence was filed on 18 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
250
Date
17 May 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+953
Change %
Price
$0.000000
Shares after
953
Date
17 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
953
Exercise price
$393.30
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .